Medindia

X

Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights

Friday, May 6, 2011 General News J E 4
Advertisement

Anadys Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

March 31,

December 31,

2011

2010

(Unaudited)

(Audited)

Assets

Cash, cash equivalents and securities available-for-sale

$

32,845

$

37,984

Other current assets

739

1,319

Noncurrent assets

188

234

        Total assets

$

33,772

$

39,537

Liabilities and Stockholders' Equity

Current liabilities

$

3,204

$

2,970

Common stock warrant liability

1,329

1,881

Other long-term liabilities

10

13

Stockholders' equity

29,229

34,673

        Total liabilities and stockholders' equity

$

33,772

$

39,537

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Da...
S
Interleukin Genetics, Inc. Announces Conference Ca...